Abstract:The NLRP3 inflammasome, as an important component of the innate immune system, plays vital roles in various metabolic disorders. It has been reported that the NLRP3 inflammasome can be activated by a broad range of distinct stimuli, such as K+ efflux, mitochondrial dysfunction, lysosomal disruption and trans-Golgi disassembly, etc. However, there has been no well-established model for NLRP3 inflammasome activation so far, especially the underlying mechanisms for mitochondria in NLRP3 inflammasome activation remain elusive. Given that K+ efflux is a widely accepted nexus for triggering activation of NLRP3 inflammasome in most previous studies, we sought to elucidate the role of mitochondria in K+ efflux-induced NLRP3 inflammasome activation. Here, we demonstrated that inflammation activation by LPS evoked the expression of genes that involved in mitochondrial biogenesis and mitophagy, subsequently mitochondrial mass and mitochondrial membrane potential were also elevated, suggesting the contribution of mitochondria in inflammatory responses. Moreover, we inhibited mitochondrial biogenesis by silencing Tfam and genetic ablation of Tfam abolished the NLRP3 inflammasome activation induced by K+ efflux via release of mitochondrial DNA (mtDNA), as deprivation of cellular mtDNA by EtBr treatment could reverse inflammasome activation induced by K+ efflux. Collectively, we reveal that mtDNA release induced by K+ efflux in macrophages activates NLRP3 inflammasome, and propose that mitochondria may serve as a potential therapeutic target for NLRP3 inflammasome-related diseases.

IITZ-01 Activates NLRP3 Inflammasome by Inducing Mitochondrial Damage

A novel mechanism for NLRP3 inflammasome activation

Mitochondrial damage activates the NLRP10 inflammasome

CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation

A role for mitochondria in NLRP3 inflammasome activation

Initiation and perpetuation of NLRP3 inflammasome activation and assembly

Niclosamide activates the NLRP3 inflammasome by intracellular acidification and mitochondrial inhibition

Small molecule inhibitor binds to NLRP3 and prevents inflammasome activation

NLRP3 inflammasome activation, metabolic danger signals, and protein binding partners

Small molecule inhibitor binds to NOD-like receptor family pyrin domain containing 3 and prevents inflammasome activation

Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

How location and cellular signaling combine to activate the NLRP3 inflammasome

Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation

Hexokinase dissociation from mitochondria promotes oligomerization of VDAC that facilitates NLRP3 inflammasome assembly and activation

New mitochondrial DNA synthesis enables NLRP3 inflammasome activation

Mechanistic basis for potassium efflux-driven activation of the human NLRP1 inflammasome

Structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation

AKT Controls NLRP3 Inflammasome Activation by Inducing DDX3X Phosphorylation

Activated MLKL functions as signal II of the NLRP3 inflammasome

Disruptions in endocytic traffic contribute to the activation of the NLRP3 inflammasome